During the analysis of phosphotyrosine-containing proteins in scirrhous gastric carcinoma cell lines, we observed an unusual expression of Arf-GAP with Rho-GAP domain, ankyrin repeat and PH domain 3 (ARAP3), a multimodular signaling protein that is a substrate of Src family kinases. Unlike other phosphotyrosine proteins, such as CUB domain-containing protein 1 (CDCP1) and Homo sapiens chromosome 9 open reading frame 10/ oxidative stress-associated Src activator (C9orf10/Ossa), which are overexpressed and hyperphosphorylated in scirrhous gastric carcinoma cell lines, ARAP3 was underexpressed in cancerous human gastric tissues. In this study, we found that overexpression of ARAP3 in the scirrhous gastric carcinoma cell lines significantly reduced peritoneal dissemination. In vitro studies also showed that ARAP3 regulated cell attachment to the extracellular matrix, as well as invasive activities. These effects were suppressed by mutations in the Rho-GTPase-activating protein (GAP) domain or in the C-terminal two tyrosine residues that are phosphorylated by Src. Thus, the expression and phosphorylation state of ARAP3 may affect the invasiveness of cancer by modulating cell adhesion and motility. Our results suggest that ARAP3 is a unique Src substrate that suppresses peritoneal dissemination of scirrhous gastric carcinoma cells.
Introduction
The prognosis of scirrhous gastric carcinoma is poor because peritoneal dissemination and rapid submucosal invasion make it refractory to cancer treatments. Therefore, the discovery of novel therapeutic targets that control the progression of scirrhous gastric carcinoma is urgently needed. However, progress has been limited by the lack of knowledge about the factors and signaling pathways that mediate peritoneal dissemination and invasion.
Previous studies have shown that Src family tyrosine kinases (SFKs) are likely to be involved in these processes. For example, increased expression and kinase activity of SFKs frequently occurs during the transformation of precancerous cells (Frame, 2002) . Activation of SFKs is also associated with tumor progression and metastasis, as well as with characteristic activities of cancer cells including proliferation, differentiation, motility, cell-extracellular matrix (ECM) adhesion, cell-cell adhesion and invasion (Brown and Cooper, 1996; Frame, 2002) .
Recently, we reported that Src substrates such as CUB domain-containing protein 1 (CDCP1) (Uekita et al., 2008) and Homo sapiens chromosome 9 open reading frame 10/oxidative stress-associated Src activator (C9orf10/Ossa) (Tanaka et al., 2009 ) are hyperphosphorylated in the peritoneal nodules formed after inoculating the scirrhous gastric carcinoma cell line 44As3 into BALB/c nude mice. In our studies, we also detected another substrate of Src, Arf-GAP with Rho-GTPase-activated protein (GAP) domain, ankyrin repeat and PH domain 3 (ARAP3), in these nodules. However, immunohistochemical analysis showed that the expression level of ARAP3 was surprisingly higher in normal gastric glands than in cancerous tissue, unlike CDCP1 and C9orf10/Ossa. ARAP3 functions as an effector of phosphoinositide 3-kinase (PI3K) by binding to phospatidyl-inositol-3,4,5-trisphosphate (PI(3,4,5)P 3 ) through pleckstrin homology (PH) domains (Krugmann et al., 2002) . On activation of PI3K signaling, ARAP3 is thought to be recruited to the plasma membrane, where it regulates lamellipodia formation and growth factor signaling (Kowanetz et al., 2004; Krugmann et al., 2004 Krugmann et al., , 2006 . ARAP3 is tyrosine-phosphorylated by Src mainly at the two tyrosine residues at the C-terminus (I et al., 2004) , whereas the biological role of tyrosine phosphorylation of ARAP3 is still unclear. In addition, the Rho-GAP domain of ARAP3 modulates the activity of Rho-family small GTPases, which regulate cytoskeletal dynamics as well as cancer invasion and metastasis. However, the relationship between these functions of ARAP3 and cancer phenotypes is not understood well.
In this study, we show that overexpression of ARAP3 in 58As9 cells, a highly metastatic scirrhous gastric carcinoma cell line, inhibited peritoneal dissemination in a mouse model. Furthermore, mutations to either the Rho-GAP domain or tyrosine phosphorylation sites of ARAP3 failed to inhibit peritoneal dissemination. ARAP3 also inhibited rapid cell-ECM adhesion and cell invasion in vitro. Our results support the hypothesis that ARAP3 suppresses the peritoneal dissemination of scirrhous gastric carcinoma cells.
Results
Expression of ARAP3 in human gastric tissues and tumor cell lines Expression of ARAP3 in human gastric tissues was examined by immunohistochemical staining using an anti-ARAP3 antibody. ARAP3 is expressed primarily on the luminal side of the fundic gland ( Figure 1a ). In human gastric cancer tissues, ARAP3 expression was lower than in non-cancerous tissue (Figures 1b and c) . Furthermore, the expression level of ARAP3 was lower in the undifferentiated type of gastric cancer than in the differentiated type (data not shown).
We also examined the expression of ARAP3 in 14 human gastric cancer cell lines (Figure 2 ). The expression of ARAP3 was very low or undetectable in 10 of these cell lines.
Roles of ARAP3 in peritoneal dissemination
To study the functional importance of ARAP3 in the peritoneal dissemination of scirrhous gastric carcinoma, we introduced ARAP3 expression vectors into 58As9 and NKPS scirrhous gastric carcinoma cell lines that expressed relatively little endogenous ARAP3 (Figure 2 ). Both the 58As9 and NKPS cell lines are highly metastatic (Yanagihara et al., 2005; Tanaka et al., 2009) . After establishing 58As9 and NKPS cells that stably expressed wild-type ARAP3, we injected the cells into the peritoneal cavities of BALB/c nude mice (Figure 3 and Supplemental Figure 1) . Compared with the parental 58As9 cell, the ARAP3-overexpressing cells formed fewer nodules on the mesentery and fatty tissues adjacent to the uterus (Figure 3b , lower panels). Essentially the same results were obtained from the analysis of ARAP3-expressing NKPS cells (Supplemental Figure 1B ).
Effects of ARAP3 expression on the characteristics of gastric cancer cells in vitro As the adhesiveness and invasiveness of scirrhous gastric carcinoma cell lines have a significant effect on peritoneal dissemination, we examined the effect of ARAP3 overexpression on the attachment of 58As9 cells to several ECM proteins, such as fibronectin, collagen Figure 1 Immunohistochemical staining of ARAP3. Non-cancerous (a) and cancerous (b) human gastric tissues are shown. The intensity of staining was evaluated and arbitrarily scored from 0 to 3. The scores from samples of non-cancerous, cancerous and fundic gland tissues are shown in (c). Upper and lower quartiles are indicated with boxes, and minimum and maximum values are indicated with bars. Blue dots indicate the scores of all samples. Average scores (Av., red line) and sample numbers (n) are also shown. ARAP3 staining was detected in the fundic gland of the non-cancerous gastric tissues and was decreased in many cancerous tissues. and vitronectin. Overexpression of ARAP3 partially suppressed the attachment of 58As9 cells to fibronectin and vitronectin (Figure 3c ), but did not affect their adhesion to collagen. In addition, we performed an in vitro invasion assay using the 58As9 cell line with or without the overexpression of ARAP3. As shown in Figure 3d , ARAP3 clearly suppressed cell migration and invasion in 58As9 cells. ARAP3 also suppresses the cell migration activities and invasiveness of NKPS cells (Supplemental Figure 1C) . However, overexpression of ARAP3 did not affect the cell growth (Supplemental Figure 2) .
We also examined the effect of knocking down ARAP3 expression by using RNA interference in the 44As3 scirrhous gastric carcinoma cell line that expressed relatively high endogenous levels of ARAP3 (Figure 2a ). ARAP3 expression was reduced in clones R3 and R5, as shown by immunoblotting ( Figure 4A ). Underexpression of ARAP3 promoted the attachment of 44As3 cells to fibronectin and vitronectin in vitro ( Figure 4A ). Moreover, an ex vivo adhesion assay, which measures the adhesiveness of gastric cancer cells to the mesothelium, showed the same results ( Figure 4C ). These results demonstrate that expression of ARAP3 may reduce the peritoneal dissemination of scirrhous gastric carcinoma cells by inhibiting cell-ECM adhesion and cell invasion. As activities of cell adhesion and invasion are strongly affected by morphological changes (Carragher and Frame, 2004) , we examined whether the expression of ARAP3 also affects the cell morphology of the gastric carcinoma cell line. Phalloidin staining showed that R3 and R5 cells formed filopodia instead of the lamellipodia observed in parental 44As3 cells ( Figure 5A ). Furthermore, introduction of wild-type ARAP3 that contained silent mutations in the target sequence of microRNA into R3 cells suppressed filopodia formation and recovered lamellipodia formation (Figure 5Ba ). Expression of mutant ARAP3 was detected with western blotting (Figure 5Bb ).
Differential roles of functional domains of ARAP3 in cell adhesion and cell invasion in vitro As ARAP3 is a multimodular protein ( Figure 6A ), we investigated the structure-function relationships of ARAP3 domains to peritoneal dissemination. We established three 58As9 cells that expressed mutant ARAP3: (1) an Arf-GAP domain mutant (R532K), (2) a Rho-GAP domain mutant (R942L) and (3) a mutant that lacks both putative tyrosine phosphorylation sites (2YF, Y1403/1408F) (I et al., 2004) (Figure 6A ). The level of tyrosine phosphorylation of the ARAP3 2YF mutant was significantly reduced compared with R532K or R942L in 58As9 cells ( Figure 6B ). As expression levels of ARAP3 were associated with cell morphology in gastric cancer cells (Figure 5 ), we performed phalloidin staining for 58As9 cells overexpressing ARAP3 mutants. R532K mutant ARAP3 suppressed filopodia formation more strongly than R942L or 2YF mutants ( Figure 6C ). None of the ARAP3 mutants affected the growth of 58As9 cells (Supplemental Figure 2) .
We also studied the effect of overexpression of each mutant ARAP3 on cell-ECM adhesion and invasion. Overexpression of the R532K mutant ARAP3 reduced the attachment of 58As9 cell lines to ECM proteins, but overexpression of the R942L and 2YF mutants did not have any effect ( Figure 7A ).
As overexpression of wild-type ARAP3 could inhibit the metastasis of 58As9 cells, we performed an in vitro migration and invasion assay with the ARAP3 mutant cells. The results of this assay were similar to the attachment assay. Specifically, overexpression of the R532K mutant inhibited cell migration and invasion, but the R942L and 2YF mutants did not have any effect ( Figure 7B ).
These results suggest that both Rho-GAP function and tyrosine phosphorylation of ARAP3 are necessary to suppress cell-ECM adhesion and invasion of gastric cancer cells. As ARAP3 can inhibit RhoA, which is required for cell invasion (Itoh et al., 1999) , we tested whether inhibition of RhoA signal by Y27632, one of the general inhibitors of Rho-associated coiled-coil kinase (ROCK), can also suppress the invasiveness of ARAP3 mutant expressing 58As9 cells. As expected, Y27632 could modestly suppress the invasiveness of the cells (Figure 7Bc ).
Functional domains of ARAP3 critical for suppressing peritoneal dissemination in vivo To investigate whether expression of mutant ARAP3 affects peritoneal dissemination in vivo, we injected the Figure 4 Expression of ARAP3 regulated cell-ECM attachment. ARAP3 was knocked down in 44As3 scirrhous gastric carcinoma cells by a microRNA knockdown system (R3 and R5 cells (A)). Cell attachment assays were performed with these cells in vitro (B) and ex vivo (C). In the ex vivo assay, the attachment of cancer cells to the mesentery was visualized by hematoxylin and eosin staining (C(a)) and quantified by cell counts (C(b) ). Knockdown of ARAP3 increased the attachment of gastric carcinoma cells to both the ECM and mesentery. cells intraperitoneally into BALB/c nude mice (Figure 8) . Parental 58As9 cells showed severe peritoneal dissemination with ascitic fluid as previously described (Yanagihara et al., 2005) . The R532K mutant suppressed production of ascitic fluid equally effectively, whereas the R942L and 2YF mutants were less effective ( Figure 8A ). Consistent with this result, expression of R532K, but not R942L and 2YF, suppressed the peritoneal dissemination of 58As9 cells, which was quantified by counting the number of mesentery nodules formed ( Figure 8B ). These results show that ARAP3 inhibits peritoneal dissemination in vivo, and that both the Rho-GAP domain and phosphotyrosine residues at the C-terminus are important for this function.
Discussion
This study showed that ARAP3 is expressed in normal fundic gland mucosa, but its expression is reduced in poorly differentiated carcinomas. ARAP3 inhibited not only cell-ECM attachment and cell invasion in vitro but also peritoneal dissemination of 58As9 cells in vivo. As adhesion to and invasion through the ECM are essential steps for peritoneal dissemination of scirrhous gastric carcinoma cells, it is hypothesized that ARAP3 suppresses peritoneal dissemination by regulating these processes enhanced in cancer cells.
We first identified ARAP3 while screening for phosphotyrosine proteins in mesentery nodules formed after inoculating nude mice with the 44As3 gastric carcinoma cell line. Unlike other phosphotyrosine proteins identified in this screening, such as FAK, CDCP1 and C9orf10/Ossa, ARAP3 was underexpressed in undifferentiated gastric cancers compared with normal fundic glands. Src pathways are implicated in cancer progression because SFK activity and expression and tyrosine phosphorylation of Src substrates are often elevated in advanced stages of cancer (Yeatman, 2004) . Although ARAP3 is a Src substrate, our results showed that tyrosine phosphorylation of ARAP3 conferred Figure 6 Expression of ARAP3 mutants. Mutations were introduced into the Arf-GAP (R532K) or Rho-GAP (R942L) domain, or into the two putative tyrosine phosphorylation sites (2YF) of ARAP3 (A). Expression and tyrosine phosphorylation profiles of 58As9 cells expressing mutant ARAP3 were verified by immunoprecipitation and immunoblotting. The relative tyrosine phosphorylation levels of ARAP3 (phosphorylated ARAP3/total ARAP3) were also calculated (B). Morphologies of cells expressing mutant ARAP3 are shown in (C). Phalloidin staining was performed on these cells. R532K mutant suppressed the filopodia formation that was observed in the parental cell line, but the R942L and 2YF mutants were not. Filopodia are indicated by white arrows. A highly magnified image of the area that is indicated by the white line is also shown in the image. Quantification of filopodia formation was performed by calculating the percentage of filopodia-positive cells (Cb). Over 100 cells were counted. SAM, sterile alpha motif; PH, pleckstrin homology domain; AR, ankyrin repeats; RA, Ras association domain (nearly conserved). a tumor suppressive activity. As a result, SFKs may phosphorylate not only oncogenic proteins but also tumor suppressor proteins such as ARAP3.
The ability of ARAP3 to suppress peritoneal dissemination was blocked by a mutation in the Rho-GAP domain, suggesting that this function is mediated by regulation of the Rho family small GTPases. In addition, loss of the C-terminal tyrosine phosphorylation sites of ARAP3 also reduced this suppressive function of ARAP3. However, it is not clear whether Rho-GAP activity and tyrosine phosphorylation of ARAP3 regulate the peritoneal dissemination using an overlapping mechanism or a signal pathway, as no information is available on the phosphotyrosinemediated signaling of ARAP3. Although we could not detect any change in the activities of Rho family small GTPases in total cell lysate (data not shown), we cannot rule out the possibility that the activation of Rho occurs at the cell surface, because ARAP3 can localize and function there (Krugmann et al., 2002) , and its expression actually affected their cytoskeletal reorganization.
Rho family small GTPases are involved in a wide range of cellular processes, such as cell morphology, adhesion and motility. For example, activation of RhoA promotes the stabilization of focal contacts, which are important in the integrin-dependent cell-ECM attachment and cell invasion (Huveneers and Danen, 2009 ). Filopodia formation is necessary for cell migration and contact sites formation. In neuronal cells, RhoA activity is necessary for the formation of filopodial protrusion induced by RhoA/ROCK signaling (Chen et al., 2006; Kim et al., 2010) . Furthermore, activation of mammalian diaphanous-related formin (mDia), which is known as an effector of RhoA, localizes at the filopodia, promotes actin filament assembly and contributes to filopodia formation (Faix and Grosse, 2006; Carramusa et al., 2007; Sarmiento et al., 2008) . Therefore, ARAP3 may suppress the cell adhesion, migration and invasion of cancer cells by inhibiting RhoA signaling through its Rho-GAP domain.
ARAP3 is a multimodular protein that can bind to several molecules such as PI(3,4,5)P3 and Src homology 2 domain containing inositol 5-phosphatase 2 (SHIP2) in vitro, possibly through its sterile alpha motif domain (Krugmann et al., 2002; Raaijmakers et al., 2007) . Our data revealed the essential role of the phosphotyrosinecontaining region of ARAP3 for the first time. It might be required to identify molecules that bind to the C-terminal region of ARAP3 in a tyrosine phosphorylationdependent manner. Further study is needed to determine Figure 7 Effects of overexpression of ARAP3 mutants in 58As9 cell lines. Adhesiveness and invasiveness were examined by a cell attachment assay (A) and a cell migration and invasion assay (Ba and Bb, respectively). Overexpressed R942L and 2YF mutants did not rapidly adhere to ECM proteins or suppress cell migration and invasion. The Rho-associated coiled-coil kinase (ROCK) inhibitor Y27632 suppressed the invasiveness of 58As9 cells expressing R942L or 2YF ARAP3 (Bc). ARAP3 may suppress the invasiveness of 58As9 cells in vitro by inhibiting RhoA activity (*Po0.05 **Po 0.01).
how the phosphotyrosine-dependent signal of ARAP3 suppresses cell-ECM attachment, migration and invasion of cancer cells.
We also observed that the Arf-GAP domain of ARAP3 regulated the internalization of epidermal growth factor receptor following epidermal growth factor stimulation (data not shown), similar to that reported in ARAP1 (Daniele et al., 2008; Yoon et al., 2008) . However, judging from the results in this study, the Arf-GAP activity of ARAP3 does not significantly contribute to the suppression of peritoneal dissemination.
Several suppressors of integrin signaling or cell-ECM adhesion have been identified as possible therapeutic targets for preventing peritoneal dissemination of scirrhous gastric carcinoma (Nishimura et al., 1996; Matsuoka et al., 1998) . Likewise, ARAP3, which regulates both cell-ECM adhesion and invasiveness, may be a novel therapeutic target. Small molecules that mimic the suppressive function of ARAP3, induce its expression or promote tyrosine phosphorylation of ARAP3 are anticipated to be effective drugs to prevent peritoneal dissemination of scirrhous gastric carcinoma cells.
Materials and methods

Materials
Anti-ARAP3 antibodies used for western blotting were purchased from Abcam (Cambridge, MA, USA), whereas those used for immunohistochemistry were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antiphosphotyrosine (4G10) antibody was obtained from Upstate Biotechnology (Lake Placid, NY, USA). Sheep antimouse antibodies and sheep antirabbit antibodies were bought from GE Healthcare (Buckinghamshire, UK). Rabbit antigoat antibodies were purchased from Zymed (Carlsbad, CA, USA). Alexa 594-conjugated phalloidin was obtained from Molecular Probes (Carlsbad, CA, USA).
Immunohistochemical staining
Paraffin-embedded tissue samples of human scirrhous or nonscirrhous gastric carcinoma were obtained from the National Cancer Center Hospital (Tokyo, Japan). Sections on glass slides were rehydrated and autoclaved at 120 1C for 10 min to reactivate the antigen. Thereafter, the specimens were immunostained using the indirect polymer method with Envision reagent (Dako, Carlsbad, CA, USA) and ARAP3 antibodies (1:500 dilution). Finally, the stained sections were examined with an Olympus BX51 microscope (Tokyo, Japan).
Cell culture Gastric cancer cell lines 44As3, 58As1, 58As9, KATO3, NKPS, TMK1 and MKN28) were maintained in RPMI 1640 medium (Sigma, St Louis, MO, USA) supplemented with 10% fetal bovine serum (Equitech-Bio, Kerrville, TX, USA) at 37 1C in a humidified atmosphere containing 5% CO 2 . G418 (600 ng/ml; Sigma) or Blasticidin (10 ng/ml; Sigma) were also included in the growth medium to select for ARAP3-overexpressing or knockdown cells, respectively.
Construction of ARAP3 Stealth RNAi, miR RNAi and pDONA1-ARAP3 retroviral vectors
The ARAP3 gene was subcloned from a pEGFP-ARAP3 plasmid into a pDON-A1 retrovirus vector, and then mutant Figure 8 Expression of ARAP3 mutants affects peritoneal dissemination of gastric carcinoma cells. 58As9 cells expressing ARAP3 mutants were injected intraperitoneally into BALB/c nude mice (4 Â 10 6 cells/mouse, n ¼ 5). Nineteen days after injection, the R532K mutant ARAP3 suppressed ascites formation and peritoneal dissemination, but the R942L and 2YF mutants did not (A and Ba). Similarly, R532K also reduced the number of mesentery nodules formed after tumor cell inoculation, whereas R942L and 2YF did not (Bb) (*Po0.05 **Po0.01).
ARAP3 plasmids were constructed using the QuickChange Site-Directed Mutagenesis Kit (Stratagene, Cedar Creek, TX, USA).
The miR RNAi design was based on the sequence of Stealth RNAi, which was designed using the BLOCK-iT RNAi designer tool (https://rnaidesigner.invitrogen.com/rnaiexpress/, Invitrogen, Carlsbad, CA, USA).
Phalloidin staining
Gastric cancer cells cultured on coverslips were fixed with 4% paraformaldehyde for 10 min at room temperature. The samples were incubated with 3% bovine serum albumin for 1 h in Tween-Tris buffered saline (TTBS), followed by incubation with Alexa-594-conjugated phalloidin in TTBS for 45 min at room temperature, and coverslips were mounted on glass slides. The samples were examined using an Olympus IX-70 confocal laser-scanning microscope or an Olympus BX51 microscope for fluorescence microscopy. Phalloidin was used at 1:500 dilutions.
Immunoprecipitation and western blotting
Whole-cell lysates of gastric cancer cells were harvested by PLC lysis buffer (50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (pH 7.5), 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM ethylene glycol tetraacetic acid, 10% glycerol, 100 mM NaF, 1% Triton X-100, 1 mM sodium orthovanadate, 10 mg/ml leupeptin, 10 mg/ml aprotinin and 1 M phenylmethylsulfonyl fluoride), and used for immunoprecipitation and immunoblotting. Equal amounts of total protein were separated by SDS-polyacrylamide gel electrophoresis and transferred to polyvinylidene fluoride membranes. The membranes were incubated with primary antibodies overnight at 4 1C, and then incubated with Horseradish peroxide (HRP)-conjugated secondary antibodies for 45 min at room temperature. Bands were detected on an X-ray film using an enhanced chemiluminescence system (Perkin elmer, Waltham, MA, USA)). Primary antibodies were used at dilutions of 1:1000 for ARAP3, 1:2000 for a-Tubulin and 1:5000 for phosphotyrosine.
Adhesion test
Cultured gastric cancer cell lines were dissociated with Hank's Balanced Salt Solution containing 0.25 mM EDTA. Cell suspensions (5 Â 10 4 cells/well) were seeded into 24-well plates coated with collagen (Nitta gelatin, Osaka, Japan), fibronectin (Sigma) or vitronectin (TaKaRa, Shiga, Japan) according to the manufacturer's procedure. After incubating the plates for 30 min at 37 1C in a humidified atmosphere containing 5% CO 2 , unattached cells were removed by washing with PBS, and then attached cells were trypsinized and counted with a Z1Coulter counter (Beckman Coulter, Brea, CA, USA).
Cell migration and invasion assays
Gastric cancer cells were dissociated with Hank's Balanced Salt Solution containing 0.25 mM EDTA. For the cell invasion assay, cell culture inserts (8.0 mM pore) were coated on the top and bottom surfaces with matrigel (10 mg/well) and fibronectin, respectively. In the cell migration assay, only the bottom surface was coated with fibronectin. Cells (2 Â 10 4 ) suspended in serum-free RPMI1640 medium were seeded into each cell culture insert. These inserts were then transferred to a culture plate containing RPMI1640 medium with 5% FBS. After incubating at 37 1C in a humidified atmosphere containing 5% CO 2 for 8 h (migration assay) or 12 h (invasion assay), the cells were fixed with 4% paraformaldehyde and stained with Giemsa staining solution. Assays were performed in triplicate.
Ex vivo cell adhesion assay Ten-millimeter square pieces of the peritoneal wall, including the peritoneum and abdominal skeletal muscle, were excised from 5-week-old BALB/c nude mice. The pieces were placed on top of a layer of 3% agarose gel in culture dishes, with the peritoneum side facing up. Equal numbers of parent 44As3 cells or 44As3 ARAP3 miR cells (4 Â 10 6 cells/dish) were seeded onto the peritoneal tissue, and then incubated in RPMI 1640 medium containing 10% FBS, 50 mg/ml gentamicin, penicillin and streptomycin for 4 weeks. Finally, the cultured peritoneal walls were removed, fixed in 4% paraformaldehyde and embedded in paraffin for histological analysis.
Inoculation of gastric tumor cells into nude mice
Gastric cancer cell lines were trypsinized, and aliquots of 4 Â 10 6 cells were injected intraperitoneally into BALB/c nude mice purchased from CLEA Japan (Tokyo, Japan). After 3 weeks, the mice were killed and dissected. These experiments were approved by the Committee for Ethics of Animal Experimentation and conducted in accordance with the Guidelines for Animal Experiments in the National Cancer Center.
